Efficacy of Gabapentin in Treating Pain in Children With SNI (Gabapentin Trial) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy of Gabapentin in Treating Pain in Children With SNI (Gabapentin Trial) — Stella

Recruiting

Back to Pain trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Canada

BC Children's Hospital, Vancouver, British Columbia

Key details

Phase

Safety & dosing

Sponsor

University of British Columbia

Collaborators

Canadian Institutes of Health Research (CIHR), Child-Bright Network

Enrollment target

~5 participants

Started

May 2021

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

6 Months – 18 Years

Last updated May 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov